New Hot Topic in IJAA!

**New Hot Topic in IJAA!**

Chloroquine and hydroxychloroquine as available weapons to fight COVID-19 (Colson et al).

Following the very recent publication of results showing the in vitro activity of chloroquine against SARS-CoV-2, data have been reported on the efficacy of this drug in patients with SARS-CoV-2-related pneumonia (named COVID-19) at different levels of severity.

Following the in vitro results, 20 clinical studies were launched in several Chinese hospitals.

The first results obtained from more than 100 patients showed the superiority of chloroquine compared with treatment of the control group in terms of reduction of exacerbation of pneumonia, duration of symptoms and delay of viral clearance, all in the absence of severe side effects. This has led in China to include chloroquine in the recommendations regarding the prevention and treatment of COVID-19 pneumonia.

Read the open access article in full:
https://www.sciencedirect.com/science/article/pii/S0924857920300820#tbl0001

Back to News